Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057746 | PMC |
| http://dx.doi.org/10.1016/j.jdcr.2021.03.046 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An Unusual Presentation of Erythema Multiforme Following the Administration of Pfizer-BioNTech COVID-19 mRNA Vaccine in a Pediatric Patient.
Cureus
April 2024
College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Coronavirus disease 2019 (COVID-19) caused a global calamity that forced emergency use authorization to Pfizer-BioNTech COVID-19 (BNT162b2) vaccine. It is efficacious in preventing symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in seronegative recipients. The safety profile is still unclear; however, commonly reported symptoms post-vaccination are fatigue, headache, muscle pain, chills, and injection-site pain.
View Article and Find Full Text PDFCutaneous manifestations, viral load, and prognosis among hospitalised patients with COVID-19: a cohort study.
Hong Kong Med J
October 2023
Division of Rheumatology and Clinical Immunology, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Introduction: Various cutaneous manifestations have been reported as symptoms of coronavirus disease 2019 (COVID-19), which may facilitate early clinical diagnosis and management. This study explored the incidence of cutaneous manifestations among hospitalised patients with COVID-19 and investigated its relationships with viral load, co-morbidities, and outcomes.
Methods: This retrospective study included adult patients admitted to a tertiary hospital for COVID-19 from July to September 2020.
Pernio and early SARS-CoV-2 variants: natural history of a prospective cohort and the role of interferon.
Br J Dermatol
October 2022
Department of Dermatology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Article Synopsis
- The study found a close correlation between new cases of pernio (skin condition) and rising COVID-19 positivity rates in Wisconsin over time.
- It also noted the connection between the occurrence of pernio and monthly temperature fluctuations in Madison, Wisconsin.
- The data suggests that environmental factors and COVID-19 trends may influence the incidence of pernio in the cohort studied.
COVID-19: The experience from Italy.
Clin Dermatol
May 2021
Dermatology Unit, ASST Lecco, Alessandro Manzoni Hospital, Lecco, Italy.
A wide range of cutaneous signs are attributed to COVID-19 infection. This retrospective study assesses the presence and impact of dermatologic manifestations related to the spread of COVID-19 in Lombardy, the geographic district with the first outbreak in Italy. A cohort of 345 patients with laboratory confirmed COVID-19 was collected from February 1, 2020 to May 31, 2020.
View Article and Find Full Text PDFNew-onset chilblains in close temporal association to mRNA-1273 vaccination.
JAAD Case Rep
June 2021
Bighorn Mohs Surgery and Dermatology Center, La Jolla, California.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!